{"id":63213,"date":"2023-07-17T06:59:22","date_gmt":"2023-07-17T11:59:22","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/remuneration-2021-22\/"},"modified":"2025-07-14T08:34:33","modified_gmt":"2025-07-14T13:34:33","slug":"remuneration-2021-22","status":"publish","type":"page","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2021-22\/","title":{"rendered":"R\u00e9mun\u00e9ration"},"content":{"rendered":"

1.<\/strong> Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e aux employ\u00e9s permanents \u00e0 temps plein s\u2019\u00e9levaient \u00e0 16 506 100 $ pour l\u2019exercice clos le 31 d\u00e9cembre 2021.<\/p>\n

2.<\/strong> Le nombre total d\u2019employ\u00e9s permanents \u00e0 temps plein au 31 mars 2022 \u00e9tait de 122.<\/p>\n

3.<\/strong> Montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux employ\u00e9s suivants pour l\u2019exercice clos le 31 d\u00e9cembre 2021 (tel que d\u00e9clar\u00e9 sur les feuillets T4 pour 2021):<\/p>\n\n\n\n\n\n\n\n\n\n
Titre <\/strong><\/th>\nR\u00e9mun\u00e9ration (feuillets T4 pour 2021)<\/strong><\/th>\nAvantages imposables (inclus dans le montant de la r\u00e9mun\u00e9ration)<\/strong><\/th>\n<\/tr>\n<\/tbody>\n
Pr\u00e9sident-directeur g\u00e9n\u00e9ral (1)*
\nPr\u00e9sident-directeur g\u00e9n\u00e9ral (2)*<\/td>\n		649 579,81 $
\n72 793,28 $<\/td>\n		32 971,53 $
\n0 $<\/td>\n<\/tr>\n
Vice-pr\u00e9sident, Lutte contre le cancer (1)
\nVice-pr\u00e9sidente, Lutte contre le cancer (2)<\/td>\n		548 600,69 $
\n27 610,56 $<\/td>\n		7 648,47 $
\n0 $<\/td>\n<\/tr>\n
Vice-pr\u00e9sident, Finances et Services de l\u2019entreprise<\/td>\n297 537,03 $<\/td>\n9 656,89 $<\/td>\n<\/tr>\n
Vice-pr\u00e9sidente, Strat\u00e9gie<\/td>\n283 870,12 $<\/td>\n4 990,50 $<\/td>\n<\/tr>\n
Vice-pr\u00e9sident, Syst\u00e8mes de lutte contre le cancer, rendement et innovation<\/td>\n284 960,58 $<\/td>\n6 080,96 $<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

*Les avantages imposables du PDG comprennent les cotisations au REER, la paie de vacances accumul\u00e9e et les primes d’avantages sociaux assur\u00e9s.<\/small><\/em><\/p>\n

4.<\/strong> Fourchettes de salaire des membres du personnel du Partenariat (en vigueur au 31 mars 2022):<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Niveau<\/strong><\/th>\nPoste<\/strong><\/th>\nFourchette de r\u00e9mun\u00e9ration annuelle<\/strong><\/th>\nNombre d\u2019employ\u00e9s permanents \u00e0 temps pleins<\/strong><\/th>\n<\/tr>\n<\/tbody>\n
9<\/td>\nDirecteurs principaux<\/td>\n139 542 $ \u2013 192 075 $<\/td>\n9<\/td>\n<\/tr>\n
8<\/td>\nDirecteurs, responsables<\/td>\n116 285 $ \u2013 160 063 $<\/td>\n6<\/td>\n<\/tr>\n
7<\/td>\nGestionnaires, gestionnaires de programmes, contr\u00f4leurs de gestion, sp\u00e9cialistes, responsables, gestionnaires de projet, architectes d\u2019entreprise<\/td>\n96 904 $ \u2013 133 386 $<\/td>\n29<\/td>\n<\/tr>\n
6<\/td>\nAnalystes, gestionnaires de programmes, gestionnaires de services, sp\u00e9cialistes, responsables, comptables principaux, d\u00e9veloppeurs Web, gestionnaires de projet<\/td>\n77 523 $ \u2013 104 885 $<\/td>\n44<\/td>\n<\/tr>\n
5<\/td>\nAnalystes, agents, gestionnaires de projet<\/td>\n68 003 $ \u2013 92 003 $<\/td>\n12<\/td>\n<\/tr>\n
4b<\/td>\nAdjoints de direction principaux<\/td>\n59 326 $ \u2013 80 705 $<\/td>\n3<\/td>\n<\/tr>\n
4<\/td>\nCoordonnateurs, adjoints de direction<\/td>\n52 326 $ \u2013 70 794 $<\/td>\n8<\/td>\n<\/tr>\n
3<\/td>\nAdjoints administratifs<\/td>\n45 900 $ \u2013 62 100 $<\/td>\n6<\/td>\n<\/tr>\n
<\/td>\n<\/td>\nT<\/strong>OTAL<\/strong><\/td>\n122*<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

*comprend 122 membres du personnel et 5 membres de la haute direction<\/small><\/em><\/p>\n

5.<\/strong> Le montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux membres du conseil d\u2019administration du Partenariat pour l\u2019exercice clos le 31 d\u00e9cembre 2021 (tel que d\u00e9clar\u00e9 \u00e0 l\u2019Agence du revenu du Canada sur les feuillets T4 pour 2021) s\u2019\u00e9levait \u00e0 150 200 $.<\/p>\n","protected":false},"excerpt":{"rendered":"

1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e aux employ\u00e9s permanents \u00e0 temps plein s\u2019\u00e9levaient \u00e0 16 506 100 $ pour l\u2019exercice clos le 31 d\u00e9cembre 2021. 2. Le nombre total d\u2019employ\u00e9s permanents \u00e0 temps plein au 31 mars 2022 \u00e9tait de 122. 3. Montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux employ\u00e9s suivants […]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"ep_exclude_from_search":false,"footnotes":""},"categories":[],"tags":[],"site-tools":[],"ppma_author":[1964],"class_list":["post-63213","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nCanadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2021-22\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e aux employ\u00e9s permanents \u00e0 temps plein s\u2019\u00e9levaient \u00e0 16 506 100 $ pour l\u2019exercice clos le 31 d\u00e9cembre 2021. 2. Le nombre total d\u2019employ\u00e9s permanents \u00e0 temps plein au 31 mars 2022 \u00e9tait de 122. 3. Montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux employ\u00e9s suivants […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2021-22\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-14T13:34:33+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/remuneration-2021-22\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/remuneration-2021-22\\\/\",\"name\":\"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2023-07-17T11:59:22+00:00\",\"dateModified\":\"2025-07-14T13:34:33+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/remuneration-2021-22\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2021-22\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer","og_description":"1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e aux employ\u00e9s permanents \u00e0 temps plein s\u2019\u00e9levaient \u00e0 16 506 100 $ pour l\u2019exercice clos le 31 d\u00e9cembre 2021. 2. Le nombre total d\u2019employ\u00e9s permanents \u00e0 temps plein au 31 mars 2022 \u00e9tait de 122. 3. Montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux employ\u00e9s suivants […]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2021-22\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2025-07-14T13:34:33+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2021-22\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2021-22\/","name":"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2023-07-17T11:59:22+00:00","dateModified":"2025-07-14T13:34:33+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2021-22\/"]}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/pages\/63213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/comments?post=63213"}],"version-history":[{"count":2,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/pages\/63213\/revisions"}],"predecessor-version":[{"id":72594,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/pages\/63213\/revisions\/72594"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=63213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/categories?post=63213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/tags?post=63213"},{"taxonomy":"site-tools","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/site-tools?post=63213"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/ppma_author?post=63213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}